Brandon J. Manley

Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy

Ali Hajiran, Mounsif Azizi, Logan Zemp et al. · The Journal of Urology · 2020 · 45 citations · Full text

Medicine, Oncology, Surgery +13

Reconnaissance of tumor immune microenvironment spatial heterogeneity in metastatic renal cell carcinoma and correlation with immunotherapy response

Ali Hajiran, Nicholas H. Chakiryan, Logan Zemp et al. · Clinical & Experimental Immunology · 2020 · 39 citations · Full text

Medicine, Immunology, Oncology +17

Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer

Nicholas H. Chakiryan, Da David Jiang, Kyle Gillis et al. · The Journal of Urology · 2021 · 36 citations

Medicine, Oncology, Urology +13

Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma

Andrew Ying-Fei Chang, Nicholas H. Chakiryan, Dongliang Du et al. · European Urology · 2022 · 34 citations · Full text

Medicine, Genetics, Oncology +16

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Phillip M. Rappold, Lynda Vuong, Josef Leibold et al. · Cancer Discovery · 2022 · 33 citations · Full text

Medicine, Immunology, Oncology +17